Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-07-22

Clinical Trial Update: The Effect of Testosterone Replacement on Endothelial Dysfunction, Inflammation and Insulin Resistance in Male Hypogonadotrophic Hypogonadism [Phase 4]

View source ↗

Summary

Phase 4 trial assessing the effects of testosterone replacement on endothelial dysfunction, inflammation, and insulin resistance in male hypogonadotrophic hypog…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Testosterone replacement therapy (testosterone)

Snippet

Sponsor: Gulhane School of Medicine | Conditions: Hypogonadotrophic Hypogonadism | Phase 4 | Status: COMPLETED